Stay updated on Pembrolizumab in Elderly Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Elderly Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference3%

- Check35 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check49 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2, indicating a minor page update. The 'Back to Top' element was removed; no other substantive changes were detected.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while key topics related to lung cancer and pharmacological action have been removed.SummaryDifference3%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Elderly Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Elderly Lung Cancer Clinical Trial page.